Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vasa Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vasa Therapeutics

Vasa Therapeutics

Seed

Vasa Therapeutics: A San Diego-based, preclinical-stage biopharmaceutical company.

HQ
San Diego, CA, US
Overview
Compare
Fundraising
Employees
Website

Vasa Therapeutics, founded in San Diego, California, is a privately held, preclinical-stage biopharmaceutical company. The company's core mission is to discover and develop transformative therapies targeting the pathophysiology of cardiovascular aging. Vasa Therapeutics focuses on addressing the growing unmet medical needs associated with heart failure, peripheral artery disease, sarcopenia, and other age-related cardiovascular conditions.

Notable affiliated individuals and investors include leading experts in cardiovascular medicine and biotechnology venture capitalists. Vasa Therapeutics has made significant strides in preclinical research, positioning itself as a pioneering force in cardiovascular aging therapeutics. The company's innovative approach has the potential to significantly impact the treatment landscape for age-related cardiovascular diseases, offering hope for improved patient outcomes and quality of life.

Vasa Therapeutics - Similar Companies

TheraVasc logo

TheraVasc

Vaso logo

Vaso

Vivasc Therapeutics logo

Vivasc Therapeutics

Vasca logo

Vasca

Vesalius Therapeutics logo

Vesalius Therapeutics

vesaliustx.com

VasoRx logo

VasoRx

vasrx.com

VasoGenix logo

VasoGenix

Vascugen logo

Vascugen

vascugen.com

Cross Vascular logo

Cross Vascular

BioCardia logo

BioCardia

Clear Vascular logo

Clear Vascular

Riparian Pharmaceuticals logo

Riparian Pharmaceuticals

Elastrin Therapeutics logo

Elastrin Therapeutics

elastrin.com

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Vascarta logo

Vascarta

vascarta.com

Vasa Therapeutics - Quick Facts

Who are Vasa Therapeutics' competitors?

Companies similar to Vasa Therapeutics include TheraVasc, Vaso, Vivasc Therapeutics and Vasca.

Where is Vasa Therapeutics' headquarters located?

Vasa Therapeutics' headquarters is located in San Diego, CA, US.

When was Vasa Therapeutics' last funding round?

Vasa Therapeutics' most recent funding round was for $2.3M (USD) in January 2024.

How much has Vasa Therapeutics raised to-date?

As of Jan 3, 2024, Vasa Therapeutics has raised a total of $8.3M (USD).

How many employees does Vasa Therapeutics have?

Vasa Therapeutics has 7 employees as of Feb 4, 2024.

Vasa Therapeutics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations